top of page

Estée Lauder at a Crossroads

  • Administrateur
  • Jun 9
  • 4 min read

Between 2019 and 2021, Estée Lauder Companies (ELC) seemed unstoppable: a portfolio of iconic brands, enviable profitability and a well-diversified global footprint. Yet the pandemic shock up-ended this trajectory. While 2022 delivered a technical rebound, fiscal 2023 and 2024 witnessed a genuine slowdown, in stark contrast with L’Oréal’s momentum. Heading into 2025, management remains cautious, guiding for another sales contraction driven chiefly by Asian travel retail. Understanding the roots of this under-performance and assessing the group’s room for manoeuvre is therefore key to gauge ELC’s value and turnaround potential.


Premium portfolio and brand DNA


Estée Lauder revolves around some 30 prestige houses: La Mer, Jo Malone London, MAC, Bobbi Brown, Tom Ford Beauty, Clinique and more. Most sit firmly in the luxury segment—or ultra-luxury for La Mer—with average prices well above mass brands. This positioning generates gross margins near 75 % and confers an aura of exclusivity, but it also exposes the company to swings in aspirational demand, particularly pronounced in China and duty-free zones. Vertical integration is limited: production is largely outsourced, yet high-end R&D (ingredients, formulation, quality control) remains internal, ensuring cutting-edge innovation and rapid time to market.


Global beauty market trends: structural growth, mounting volatility


The sector grows roughly 5 % a year long-term, driven by rising middle classes, an ageing population and e-commerce. Online sales climbed from 10 % in 2019 to nearly 30 % in 2024—a shift favouring brands strong in digital storytelling and direct sales. Asia-Pacific already accounts for more than 40 % of premium beauty spend, making dependence on that region strategic yet risky. Finally, travel retail—around 30 % of ELC revenue pre-COVID—remains highly sensitive to tourist flows and local regulations, as the Chinese crackdown on “daigou” resellers illustrates.


Financial trajectory 2019-2024: two consecutive down years


After a pandemic dip to $14.3 bn (2020), revenue rebounded to $17.7 bn in 2022. Momentum then reversed: $15.9 bn in 2023 (-10 %) and $15.6 bn in 2024 (-2 %). Three factors explain the relapse:

  1. Travel-retail rout: duty-free sales in Hainan and Seoul collapsed once Beijing restricted reseller purchases.

  2. Slower-than-expected Chinese reopen: domestic high-end demand never fully returned to 2019 levels.

  3. North-American normalisation: the post-lockdown make-up boom faded.

By contrast, L’Oréal maintained mid-single-digit growth, insulated by a more balanced portfolio (mass + luxe) and strong European base.


EMEA and Asia-Pacific focus: dependence becomes weakness


In Q3 FY2025, EMEA plunged -18 %. European travel retail (airports, tourist hubs) stayed muted, and inflation curbed local spending in the UK, France and Germany. Asia-Pacific, once the engine, slipped -3 %. Hong Kong and South-Korea suffered from the end of the daigou model; mainland China eked out a mid-single-digit gain—insufficient for offsetting declines elsewhere. ELC’s historic reliance on these two regions (over 60 % of pre-COVID sales) has clearly backfired.


Margin pressure: impairments, inflation and aggressive marketing


Gross margin holds near 75 % thanks to pricing and premium mix. Operating costs, however, ballooned. Brand impairments (Smashbox, Dr. Jart+) total almost $700 m over 2023-2024, highlighting difficulties monetising some Asian acquisitions. Restructuring charges, soaring logistics and packaging costs, plus heavier digital promotions, all eat into EBIT. Net profit fell to $0.39 bn in 2024—less than a 3 % margin.


ree

A balance-sheet weighed down by acquisitions


Gross debt is roughly $9 bn, cash $4 bn, leaving net debt of $5-6 bn. The net-debt/EBITDA ratio has jumped above 3×, threatening the group’s “A” credit rating. The pricey Tom Ford Beauty purchase ($2.3 bn cash) and prior share buy-backs swell the burden. With operating cash flow halved in three years, flexibility is shrinking. Persistently high rates could further raise interest costs.


Turnaround levers: a demanding yet credible roadmap


Management sets out five priorities:

  • Rebalance geography: accelerate in Latin America, India and the Middle East—faster-growing, tourist-light regions.

  • Revive skincare innovation: premium science is ELC’s DNA. Launches featuring encapsulated retinol and regenerative peptides are slated for 2026.

  • Scale direct-to-consumer: target 40 % online sales by 2027 via livestreams, social commerce and exclusive memberships.

  • Optimise travel-retail footprint: exit low-profit doors, renegotiate consignment terms and align inventory to normal demand.

  • Financial discipline: pause buybacks, temper dividends and roll out a cost-saving plan (2 000 job cuts) to restore double-digit operating margins by 2027.

The challenge: preserving luxury equity while cutting spend.


Strategic comparison with L’Oréal: diversification as shield

The recent divergence stems mainly from diversification. L’Oréal mixes luxury, dermocosmetics, mass and professional hair: when one leg weakens, another steadies the ship. Its geographic split is more balanced (Europe ≈34 % of revenue) and e-commerce exceeds 30 %. With R&D spend at 4 % of sales versus roughly 2.5 % for ELC, its innovation pipeline is broader. Key lesson: over-specialisation in high-end beauty and Asian duty-free can turn into an Achilles’ heel during turmoil.


Conclusion: a jewel seeking resilience


Estée Lauder remains one of the few pure-play luxury beauty groups, with priceless brand equity and unrivalled gross margins. Yet the post-COVID reality exposed over-reliance on Asian travel retail, premium Chinese consumers and limited diversification. Recovery hinges on reallocating capital to e-commerce, skincare innovation and emerging-market growth outside duty-free. If management executes without diluting the luxury aura and restores a sound balance sheet, ELC could regain a sustainable growth path from 2026. Otherwise, market-share losses may accelerate in favour of nimbler rivals. For investors, ELC stands at a pivotal juncture: its ability to convert current weaknesses into opportunities will determine its worth in the beauty landscape of the 2030s.




Recent Posts

See All

Comments


Privacy Policy

Legal Notice

Cookie Policy

bottom of page